SCHEMBL74247

SCHEMBL74247

Clc1ccc(C2(Cn3cncn3)CO2)c(Cl)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.74
CYP2C9 P11712 3/20 0.74
THRB P10828 1/20 0.63
KDM4E B2RXH2 1/20 0.50
LMNA P02545 2/20 0.45
TSHR P16473 2/20 0.45
NR1I2 O75469 1/20 0.45
FYN P06241 1/20 0.45
PGR P06401 1/20 0.45
HSP90AA1 P07900 1/20 0.45
CHRM2 P08172 1/20 0.45
CHRM4 P08173 1/20 0.45
CHRM5 P08912 1/20 0.45
ADRA2A P08913 1/20 0.45
CHRM1 P11229 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
CHRM3 P20309 1/20 0.45
DRD1 P21728 1/20 0.45
TBXA2R P21731 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10512062 0.91 CYP3A4 (0.64) CYP3A4CYP2C9THRBKDM4ELMNA
SCHEMBL11134303 0.91 CYP3A4 (0.64) CYP3A4CYP2C9THRBKDM4ELMNA
SCHEMBL10594823 0.89 CYP3A4 (0.65) CYP3A4CYP2C9THRBKDM4ELMNA
SCHEMBL9302829 0.88 CYP3A4 (0.64) CYP3A4CYP2C9THRBKDM4ELMNA
SCHEMBL9597393 0.87 CYP3A4 (0.78) CYP3A4CYP2C9THRBKDM4ELMNA
Bromuconazole SCHEMBL3682832 0.86 CYP3A4 (1.00) CYP3A4CYP2C9THRBKDM4ELMNA
Bromuconazole SCHEMBL29360340 0.86 CYP3A4 (1.00) CYP3A4CYP2C9THRBKDM4ELMNA
SCHEMBL9597099 0.86 CYP3A4 (0.77) CYP3A4CYP2C9THRBKDM4ELMNA
Bromuconazole SCHEMBL22340 0.86 CYP3A4 (1.00) CYP3A4CYP2C9THRBKDM4ELMNA
SCHEMBL10596297 0.85 CYP3A4 (0.61) CYP3A4CYP2C9THRBKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0095828-B1 ANTIFUNGAL TRIAZOLYL PROPANOL DERIVATIVES Pfizer Limited (GB) 1986-02-26 EP claimed
EP-0095828-A1 Antifungal triazolyl propanol derivatives Pfizer Limited (GB) 1983-12-07 EP claimed
WO-2020122766-A1 HYBRID AMIDES EXHIBITING ANTI-MICROBIAL ACTIVITY ЛЕВШИН, Игорь Борисович 2020-06-18 WO disclosed
US-20180194742-A1 Antifungal Compounds UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-07-12 US disclosed
US-20180194742-A1 Antifungal Compounds UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-07-12 US disclosed
EP-2337562-B1 ANTIFUNGAL COMPOUNDS CONTAINING BENZOTHIAZINONE, BENZOXAZINONE OR BENZOXAZOLINONE AND PROCESS THEREOF COUNCIL SCIENT IND RES (IN) 2013-07-24 EP disclosed
EP-2346861-B1 THIOPHENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS THEREOF COUNCIL SCIENT IND RES (IN) 2013-01-23 EP disclosed
US-8236840-B2 Thiopene containing analogues of fluconazole as antifungal agents and process for their preparation COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-08-07 US disclosed
US-8129369-B2 Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof Council of Scientific & Industrial Research; (US) 2012-03-06 US disclosed
US-20110183968-A1 ANTIFUNGAL COMPOUNDS CONTAINING BENZOTHIAZINONE, BENZOXAZINONE OR BENZOXAZOLINONE AND PROCESS THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2011-07-28 US disclosed
EP-2346861-A2 THIOPHENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS THEREOF Council of Scientific and Industrial Research (IN) 2011-07-27 EP disclosed
EP-0115400-A1 Triazole antifungal agents Pfizer Limited (GB) 1984-08-08 EP disclosed
EP-0113509-A2 1,3-Bis(triazolyl)-2-amino-2-aryl-propane derivatives and pharmaceutical fungicidal compositions containing them Pfizer Limited (GB) 1984-07-18 EP disclosed
EP-0111658-A2 1,3-Dihalopropan-2-ols IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-06-27 EP disclosed
EP-0107392-A1 Triazole antifungal agents Pfizer Limited (GB) 1984-05-02 EP disclosed
EP-0106515-A2 Triazole anti-fungal agents Pfizer Limited (GB) 1984-04-25 EP disclosed
EP-0095828-A1 Antifungal triazolyl propanol derivatives Pfizer Limited (GB) 1983-12-07 EP disclosed
US-4416682-A 1,3-Bis(azolyl)propanols as fungicides and plant growth regulators IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-11-22 US disclosed
EP-0091309-A2 Triazole antifungal agents Pfizer Limited (GB) 1983-10-12 EP disclosed
EP-0044605-A1 Fungicidal bis-azolyl compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-01-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194742-A1 Antifungal Compounds ERG28, DPM1, CYP51A1 CYP3A4 431/4885CYP2C9 1058/4885THRB 4744/4885
US-20110183968-A1 ANTIFUNGAL COMPOUNDS CONTAINING BENZOTHIAZINONE, BENZOXAZINONE OR BENZOXAZOLINONE AND PROCESS THEREOF CYP51A1, XPO1, XPO5 CYP3A4 13/4885CYP2C9 37/4885THRB 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.